Drug intelligence / Profile preview

WD-3

Development stage
Preclinical
Lead developer
Wuxi Hospital of Traditional Chinese Medicine
Administration
Oral
01

Overview

**WD-3** is a proprietary traditional Chinese medicine herbal decoction formula, also called Weitiao No. 3, created at Wuxi Hospital of Traditional Chinese Medicine for use in advanced non-small cell lung cancer with a traditional Chinese medicine qi-deficiency pattern. It comprises eleven Chinese herbs and is administered orally. Clinical and translational reports have evaluated WD-3 as an adjunct to PD-1 or PD-L1 checkpoint inhibition plus chemotherapy, with proposed activity involving remodeling of the gut microbiota and tumor immune microenvironment, including effects on regulatory T cells. Its individual active constituents and direct molecular targets have not been definitively established. ([link.springer.com](https://link.springer.com/article/10.1186/s12575-025-00320-2))

Other names
Weidiao No. 3 FormulaWeitiao No. 3 decoction微调3号方

Beyond the preview

Go deeper on WD-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call